IBM
58
-2
EMN
60
4
PG
56
5
DHI
48
4
AA
48
-12
PRGO
39
3
ISRG
74
-2
BWA
48
2
FTI
81
5
DD
63
3
RSG
71
3
FDX
43
3
ROST
63
12
PFG
45
3
MSFT
50
3
CA
38
6
AN
58
4
AXP
71
2
AON
54
2
LB
63
22
IBM
58
-2
EMN
60
4
PG
56
5
DHI
48
4
AA
48
-12
PRGO
39
3
ISRG
74
-2
BWA
48
2
FTI
81
5
DD
63
3
RSG
71
3
FDX
43
3
ROST
63
12
PFG
45
3
MSFT
50
3
CA
38
6
AN
58
4
AXP
71
2
AON
54
2
LB
63
22
Financhill
Back

The Oncology Institute 10K Form

Sell
25

TOI
The Oncology Institute

Last Price:
0.16
Seasonality Move:
-8.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $324.24M
Cash Flow: $1.22M
Price / Cash Flow: 0
Annual Sales: $0.20
Price / Book: 0.75

Profitability

EPS (TTM): -0.78000
Net Income (TTM): $-70.24M
Gross Margin: $59.57M
Return on Equity: -163.45%
Return on Assets: -35.44%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 5 years for TOI is 18.37%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 35.11% of Gross Profit Margin.
  • The Interest Expense is -8.16% of Operating Income.
  • The Net Earning history of TOI is -25.62% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 5.91
Current Ratio: 2.49
Quick Ratio: 2.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Sell
25
The Oncology Institute (TOI) is a Sell

Is The Oncology Institute a Buy or a Sell?